Natural Brain Dopings: Plant Derived Nootropics and Their Cognitive Effects

Abstract

With increasing global life expectancy, there is an increase in the elderly population and the prevalence of age-related cognitive disorders. Cognitive impairment is a global health problem that causes individual, economic, and social burdens. Nootropics are substances that help increase cognitive performance by affecting the dopaminergic, glutamatergic/cholinergic, and serotonergic systems in the brain. Nootropics are examined in two groups: synthetic and natural/plant-derived. Research has focused on plant-derived nootropics that reduce the incidence of side effects of synthetic nootropics and can target more than one pathway, either alone or in combination with traditional medications. Plant-derived nootropic agents include Ginkgo biloba, Panax quinquefolius, Panax ginseng, Bacopa monnieri, gotu kola (Centella asiatica), lion's mane (Hericium erinaceus), kapikacchu (Mucuna pruriens), ashwagandha (Withania somnifera), flavonoids, St. John's Wort, sage, peppermint, and caffeine. Plant-derived nootropics can be an effective treatment for cognitive functions and neurodegenerative disorders, but the ingredients and preparation of these products may vary depending on genetic, cultural, and environmental factors. For this reason, it is important to ensure standardization to increase the efficiency, quality, and reliability of products. Unlike synthetic nootropics, plant-derived nootropics contain phytochemical components that have positive effects on cognitive functions. The usage of plant-derived nootropics should take into account factors, including nutrition, drug interactions, disease comorbidities, and pregnancy.

Keywords

• Plant derived nootropics
• cognitive functions
• dementia
• Alzheimer

Doğal Beyin Dopingleri: Bitkisel Nootropikler ve Bilişsel Etkileri

Abstract

Artan küresel ortalama yaşam beklentisi ile birlikte yaşlı nüfusta ve yaşa bağlı bilişsel bozuklukların prevalansında artış görülmektedir. Bilişsel bozulma; bireysel, ekonomik ve toplumsal yüke neden olan küresel bir sağlık sorunudur. Nootropikler, beyinde dopaminerjik, glutamaterjik/kolinerjik ve serotonerjik sistemleri etkileyerek bilişsel performansı artırmaya yardımcı olan bileşiklerdir. Nootropikler; sentetik ve doğal/ bitkisel olmak üzere iki grupta incelenirler. Araştırmalar, sentetik nootropiklerin yan etki insidansını azaltan ve tek başına veya geleneksel ilaçlarla kombinasyon halinde birden fazla yolu hedefleyebilen bitkisel nootropikler üzerinde yoğunlaşmıştır. Bitkisel nootropik ajanlar arasında Ginkgo biloba, Panax quinquefolius, Panax ginseng, Bacopa monnieri, gotu kola (Centella asiatica), aslan yelesi (Hericium erinaceus), kapikacchu (Mucuna pruriens), ashwagandha (Withania somnifera), flavonoidler, sarı kantaron, adaçayı, nane ve kafein yer almaktadır Bitkisel nootropikler, bilişsel işlevler ve nörodejeneratif bozukluklar için etkili bir tedavi olabilir, ancak bu ürünlerin içeriği ve hazırlanışı, genetik, kültürel ve çevresel faktörlere bağlı olarak değişebilir. Bu nedenle ürünlerin etkinliği, kalitesi ve güvenilirliğinin artması için standardizasyonun sağlanması önemlidir. Sentetik nootropiklerin aksine bitkisel nootropikler bilişsel fonksiyonlar üzerinde olumlu etkiler gösteren fitokimyasal bileşenler içerir. Bitkisel nootropiklerin kullanımında diyet, ilaç etkileşimleri, hastalık komorbiditeleri ve gebelik gibi faktörler göz önünde bulundurulmalıdır.

Keywords

• Bitkisel nootropikler
• bilişsel fonksiyonlar
• demans
• Alzheimer hastalığı.

References

1. Chen Y, Demnitz N, Yamamoto S, Yaffe K, Lawlor B, Leroi I. Defining brain health: A concept analysis. Int J Geriatr Psychiatry. 2021;37(1).
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
3. Harvey PD. Domains of cognition and their assessment. Dialogues Clin Neurosci. 2019;21(3):227-37.
4. Aubé D. Cognitive Health, a New Target for Healthy Aging. 2018. [Updated 2018 June 22; cited 2023 May 25]. Available from: https://www. inspq.qc.ca/node/12063.
5. Murman DL. The Impact of Age on Cognition. Semin Hear. 2015;36(3):111-21.
6. Biggio G, Di Fazio I, Martini C. Cognitive function modulation during aging: A focus on L-alpha-GPE. Eur Rev Med Pharmacol Sci. 2021;25(7):3015-27.
7. Organization for Economic Co-operation and Development (OECD). Life expectancy at birth. 2023 [cited 2024 Jan 2]. Available from: https:// www.oecd-ilibrary.org/sites/d90b402d-en/index.html?itemId=/content/ component/d90b402d-en#.
8. Onaolapo AY, Obelawo AY, Onaolapo OJ. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline. Curr Aging Sci. 2019;12(1):2-14.

9. Sergiev PV, Dontsova OA, Berezkin GV. Theories of Aging: An Ever- Evolving Field. Acta Naturae. 2015;7(1):9-18.
10. Tamer CE, Temel SG, Suna S, Karabacak AO, Ozcan T, Ersan LY, et al. Evaluation of bioaccessibility and functional properties of kombucha beverages fortified with different medicinal plant extracts. Turk J Agric For. 2021;45(1):13-32.
11. Al Akeel MM, Al Ghamdi WM, Al Habib S, Koshm M, Al Otaibi F. Herbal medicines: Saudi population knowledge, attitude, and practice at a glance. J Family Med Prim Care. 2018;7(5):865-75.
12. Giurgea C. [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology]. Actual Pharmacol (Paris). 1972;25:115-56.
13. Malik M, Tlustoš P. Nootropic herbs, shrubs, and trees as potential cognitive enhancers. Plants (Basel). 2023;12(6):1364.
14. Suliman NA, Mat Taib CN, Mohd Moklas MA, Adenan MI, Hidayat Baharuldin MT, Basir R. Establishing natural nootropics: Recent molecular enhancement influenced by natural nootropic. Evid Based Complement Alternat Med. 2016;2016:4391375.
15. Malik M, Tlustoš P. Nootropics as cognitive enhancers: Types, dosage and side effects of smart drugs. Nutrients. 2022;14(16):3367.
16. Voronina TA. Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects. Neurochem. J. 2023;17(2):180-188.
17. Fang J, Wang Z, Wang P, Wang, M. Extraction, structure and bioactivities of the polysaccharides from Ginkgo biloba: A review. Int. J. Biol. Macromol. 2020;162:1897-1905.
18. Serrano-Garcia N, Pedraza-Chaverri J, Mares-Samano JJ, Orozco-Ibarra M, Cruz-Salgado A, Jimenez-Anguiano A, et al. Antiapoptotic effects of EGb 761. Evid Based Complement Alternat Med. 2013;2013:495703.
19. Wang F, Ye S, Ding Y, Ma Z, Zhao Q, Zang M, Li Y. (2022). Research on structure and antioxidant activity of polysaccharides from Ginkgo biloba leaves. J. Mol. Struct. 2022;1252:132185.
20. Christen Y. Ginkgo biloba and neurodegenerative disorders. Front Biosci. 2004;9:3091-104.
21. Taylor JE. [Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract]. Presse Med. 1986;15(31):1491-3.
22. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, et. al. Ginkgo Evaluation of Memory (GEM) Study Investigators. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. Jama.2008:300(19): 2253-62.
23. Băjenaru O, Prada G, Antochi F, Jianu C, Tudose C, Cuciureanu A, et. al. Effectiveness and safety profile of Ginkgo biloba standardized extract (EGb761R) in patients with amnestic mild cognitive impairment. CNS Neurol Disord Drug Targets. 2021:20(4): 378-84.
24. Stough C, Clarke J, Lloyd J, Nathan PJ. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol. 2001;4(2):131-4.
25. Dincel D, Aydemir GG, Altınbaşak O, Altınbaşak BB, Mayda PY. (2023). A Review of Medicinal Properties of Ginkgo biloba L. Journal of Kocaeli Health and Technology University.2023;1(1): 1-19.
26. Baeg IH, So SH. The world ginseng market and the ginseng (Korea). J Ginseng Res. 2013;37(1):1-7.
27. Flagg AJ. Traditional and current use of ginseng. Nurs Clin North Am;2021:56(1), 109-21.
28. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav. 2003;75(3):687-700.
29. Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, et al. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol. 2008;15(8):865-8.
30. Hadjiivanova CI, Petkov VV. Effect of Ginkgo biloba extract on beta-adrenergic receptors in different rat brain regions. Phytother Res. 2002;16(5):488-90.
31. Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22(3):222-6.
32. Lee Y, Oh S. Administration of red ginseng ameliorates memory decline in aged mice. J Ginseng Res. 2015;39(3):250-6.
33. Li WK, Fitzloff JF. HPLC determination of ginsenosides content in ginseng dietary supplements using ultraviolet detection. J Liq Chromatogr Relat Technol. 2002;25(16):2485-500.
34. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A. 2002;99(19):12197-202.
35. Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K, et al. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl). 2010;212(3):345-56.
36. Chen EYH, Hui CLM. HT1001, A Proprietary North American Ginseng Extract, Improves Working Memory in Schizophrenia: A Double-blind, Placebo-Controlled Study. Phytother Res. 2012;26(8):1166-72.
37. Kulkarni R, Girish KJ, Kumar A. Nootropic herbs (Medhya Rasayana) in Ayurveda: An update. Pharmacogn Rev. 2012;6(12):147-53.
38. Dinh TPA, Thuy LT, Thuy My NT, Nguyen VT, Tram LH, Nguyen TA, et. al. (2023). Phenyl glycosides from Bacopa monnieri with their antioxidant and anti-inflammatory activities. Nat. Prod. Res. 2023:1-6.
39. Anand T NM, Swamy MSL, Khanum F. Antioxidant and DNA damage preventive properties of Bacopa monniera (L) wettst. Free Rad Antiox. 2011;1(1):84-90.
40. Geetha PS, Kanchana S, Pasupathi E, Murugan M, Rohini C. A review on putative mechanism of action of nootropic herb Bacopa monnieri. Pharm Innov J. 2021;11:4-5.
41. Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl). 2001;156(4):481-4.
42. Stough C, Downey LA, Lloyd J, Silber B, Redman S, Hutchison C, et al. Examining the Nootropic Effects of a special extract of Bacopa monniera on Human Cognitive Functioning: 90 day Double-Blind Placebo-Controlled Randomized Trial. Phytother Res. 2008;22(12):1629-34.
43. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An Acute, Double-Blind, Placebo-Controlled Cross-over Study of 320 mg and 640 mg Doses of Bacopa monnieri (CDRI 08) on Multitasking Stress Reactivity and Mood. Phytother Res. 2014;28(4):551-9.
44. Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebocontrolled, double-blind trial. J Altern Complement Med. 2010;16(7):753-9.
45. Barbhaiya HC, Desai RP, Saxena VS, Pravina K, Wasim P, Geetharani P, et al. Efficacy and tolerability of BacoMind on memory improvement in elderly participants—a double blind placebo controlled study. J Pharmacol Toxicol. 2008;3(6):425-34.
46. Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707-13.
47. Kumar N, Abichandani LG, Thawani V, Gharpure KJ, Naidu MUR, Ramana GV. Efficacy of standardized extract of Bacopa monnieri (Bacognize (R)) on cognitive functions of medical students: a six-week, randomized placebo-controlled trial. Evid Based Complement Alternat Med. 2016;2016:4103423.
48. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. 2014;28(4):551-9.
49. Usha P, Wasim P, Joshua J, Geetharani P, Murali B, Mayachari AS, et al. BacoMindR: A cognitive enhancer in children requiring individual education programme. J Pharmacol Toxicol. 2008;3(4):302-10.
50. Chandrika UG, Prasad Kumarab PA. Gotu Kola (Centella asiatica): Nutritional properties and plausible health benefits. Adv Food Nutr Res. 2015;76:125-57.
51. Puttarak P, Dilokthornsakul P, Saokaew S, Dhippayom T, Kongkaew C, Sruamsiri R, et al. Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A systematic review and meta-analysis. Sci Rep. 2017;7(1):10646.
52. Wattanathorn J, Mator L, Muchimapura S, Tongun T, Pasuriwong O, Piyawatkul N, et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Ethnopharmacol. 2008;116(2):325-32.
53. Kumar MHV, Gupta YK. Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats. J Ethnopharmacol. 2002;79(2):253-60.
54. Rao SB, Chetana M, Devi PU. Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol Behav. 2005;86(4):449-57.
55. Lopresti AL. Salvia (Sage): A Review of its potential cognitiveenhancing and protective effects. Drugs R D. 2017;17(1):53-64.
56. Miroddi M, Navarra M, Quattropani MC, Calapai F, Gangemi S, Calapai G. Systematic review of clinical trials assessing pharmacological properties of salvia species on memory, cognitive impairment and alzheimer's disease. Cns Neurosci Ther. 2014;20(6):485-95.
57. Kennedy DO, Dodd FL, Robertson BC, Okello EJ, Reay JL, Scholey AB, et al. Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J Psychopharmacol. 2011;25(8):1088-100.
58. Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav. 2005;83(5):699-709.
59. Scholey AB, Tildesley NTJ, Ballard CG, Wesnes KA, Tasker A, Perry EK, et al. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology. 2008;198(1):127-39.
60. Shinjyo N, Green J. Are sage, rosemary and lemon balm effective interventions in dementia? A narrative review of the clinical evidence. Eur J Integr Med. 2017;15:83-96.
61. Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav. 2003;75(3):651-9.
62. Ulbricht C, Costa D, Grimes Serrano JM, Guilford J, Isaac R, Seamon E, et al. An evidence-based systematic review of spearmint by the natural standard research collaboration. J Diet Suppl. 2010;7(2):179-215.
63. Vladimir-Knezevic S, Blazekovic B, Kindl M, Vladic J, Lower-Nedza AD, Brantner AH. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the lamiaceae family. Molecules. 2014;19(1):767-82.
64. Nieman KM, Sanoshy KD, Bresciani L, Schild AL, Kelley KM, Lawless AL, et al. Tolerance, bioavailability, and potential cognitive health implications of a distinct aqueous spearmint extract. Funct Foods Health Dis. 2015;5(5):165-87.
65. Herrlinger KA, Nieman KM, Sanoshy KD, Fonseca BA, Lasrado JA, Schild AL, et al. Spearmint extract ımproves working memory in men and women with age-associated memory impairment. J Altern Complement Med. 2018;24(1):37-47.
66. Falcone PH, Nieman KM, Tribby AC, Vogel RM, Joy JM, Moon JR, et al. The attention-enhancing effects of spearmint extract supplementation in healthy men and women: a randomized, double-blind, placebocontrolled, parallel trial. Nutr Res. 2019;64:24-38.
67. Panche AN, Diwan AD, Chandra SR. Flavonoids: An overview. J Nutr Sci. 2016;5:e47.
68. Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012;78(15):1138-45.
69. Lau H, Shahar S, Mohamad M, Rajab NF, Yahya HM, Din NC, et al. The effects of six months Persicaria minor extract supplement among older adults with mild cognitive impairment: a double-blinded, randomized, and placebo-controlled trial. BMC Complement Med Ther. 2020;20(1):315.
70. Bell L, Whyte AR, Lamport DJ, Spencer JPE, Butler LT, Williams CM. Grape seed polyphenol extract and cognitive function in healthy young adults: a randomised, placebo-controlled, parallel-groups acute-onchronic trial. Nutr Neurosci. 2022;25(1):54-63.
71. Schandry R, Duschek S. The effect of Camphor-Crataegus berryextract combination on blood pressure and mental functions in chronic hypotension - A randomized placebo controlled double blind design. Phytomedicine. 2008;15(11):914-22.
72. Lamport DJ, Pal D, Macready AL, Barbosa-Boucas S, Fletcher JM, Williams CM, et al. The effects of flavanone-rich citrus juice on cognitive function and cerebral blood flow: an acute, randomised, placebo-controlled cross-over trial in healthy, young adults. Br J Nutr. 2016;116(12):2160-8.
73. Bell L, Lamport DJ, Butler LT, Williams CM. A review of the cognitive effects observed in humans following acute supplementation with flavonoids, and their associated mechanisms of action. Nutrients. 2015;7(12):10290-306.
74. Haskell-Ramsay CF, Stuart RC, Okello EJ, Watson AW. Cognitive and mood improvements following acute supplementation with purple grape juice in healthy young adults. Eur J Nutr. 2017;56(8):2621-31.
75. Bell L, Williams CM. A pilot dose-response study of the acute effects of haskap berry extract (Lonicera caerulea L.) on cognition, mood, and blood pressure in older adults. Eur J Nutr. 2019;58(8):3325-34.
76. Traupe I, Giacalone M, Agrimi J, Baroncini M, Pome A, Fabiani D, et al. Postoperative cognitive dysfunction and short-term neuroprotection from blueberries: a pilot study. Minerva Anestesiol. 2018;84(12):1352-60.
77. Liu Y, Fly AD, Wang Z, Klaunig JE. The effects of green tea extract on working memory in healthy women. J Nutr Health Aging. 2018;22(3):446-50.
78. Schmidt A, Hammann F, Wolnerhanssen B, Meyer-Gerspach AC, Drewe J, Beglinger C, et al. Green tea extract enhances parieto-frontal connectivity during working memory processing. Psychopharmacology (Berl). 2014;231(19):3879-88.
79. Park SK, Jung IC, Lee WK, Lee YS, Park HK, Go HJ, et al. A combination of green tea extract and l-theanine ımproves memory and attention in subjects with mild cognitive impairment: A double-blind placebocontrolled study. J Med Food. 2011;14(4):334-43.
80. Thaung Zaw JJ, Howe PR, Evans HM, Wong RH. Cerebrovascular, cognitive and glycaemic benefits of long-term resveratrol supplementation in postmenopausal women. Alzheimers Dement. 2019;15(7):235-6.
81. Evans HM, Howe PRC, Wong RHX. Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; A 14-week randomised placebo-controlled intervention trial. Nutrients. 2017;9(1):27.
82. Zirak N, Shafiee M, Soltani G, Mirzaei M, Sahebkar A. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. J Cell Physiol. 2019;234(6):8496-508.
83. Nobakht, S. Z., Akaberi, M., Mohammadpour, A. H., Moghadam, A. T., & Emami, S. A. Traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci. 2022;25(9):1045-1058.
84. Ellis KA, Stough C, Vitetta L, Heinrich K, Nathan PJ. An investigation into the acute nootropic effects of Hypericum perforatum L. (St. John's Wort) in healthy human volunteers. Behav Pharmacol. 2001;12(3):173-82.
85. Siepmann M, Krause S, Joraschky P, Muck-Weymann M, Kirch W. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: A comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol. 2002;54(3):277-82.
86. Yechiam E, Ben-Eliezer D, Ashby NJS, Bar-Shaked M. The acute effect of Hypericum perforatum on short-term memory in healthy adults. Psychopharmacology. 2019;236(2):613-23.
87. Warren MB, Cowen PJ, Harmer CJ. Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers. J Psychopharmacol. 2019;33(2):194-201.
88. Camfield DA, Scholey AB, Pipingas A, Silberstein RB, Kure C, Zangara A, et al. The neurocognitive effects of Hypericum perforatum Special Extract (Ze 117) during smoking cessation. Phytother Res. 2013;27(11):1605-13.
89. Osz, B. E., Jitca, G., Stefanescu, R. E., Puscas, A., Tero-Vescan, A., & Vari, C. E. Caffeine and Its Antioxidant Properties-It Is All about Dose and Source. Int J Mol Sci. 2022;23(21):1034.
90. Verster JC, Koenig J. Caffeine intake and its sources: A review of national representative studies. Crit Rev Food Sci. 2018;58(8):1250-9.
91. Cappelletti S, Daria P, Sani G, Aromatario M. Caffeine: Cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13(1):71-88.
92. Pinheiro, B. G., Luz, D. A., Cartagenes, S. C., Fernandes, L. M. P., Farias, S. V., Kobayashi, N. H. C., Fontes-Junior, E. A., Ferreira, S. G., Cunha, R. A., Prediger, R. D., & Maia, C. The role of the adenosine system on emotional and cognitive disturbances induced by ethanol binge drinking in the ımmature brain and the beneficial effects of caffeine. Pharmaceuticals (Basel). 2022;15(11).
93. Park CA, Kang CK, Son YD, Choi EJ, Kim SH, Oh ST, et al. The effects of caffeine ingestion on cortical areas: Functional imaging study. Magn Reson Imaging. 2014;32(4):366-71.
94. Kanchanatawan B, Tangwongchai S, Sughondhabhirom A, Suppapitiporn S, Hemrunrojn S, Carvalho AF, et al. Add-on treatment with curcumin has antidepressive effects in Thai patients with majör depression: Results of a randomized double-blind placebo-controlled study. Neurotox Res. 2018;33(3):621-33.
95. Benson S, Tiplady B, Scholey A. Attentional and working memory performance following alcohol and energy drink: A randomised, doubleblind, placebo-controlled, factorial design laboratory study. PloS One. 2019;14(1):e0209239.
96. Srivastava S, Mennemeier M, Pimple S. Effect of Alpinia galanga on mental alertness and sustained attention with or without caffeine: A randomized placebo-controlled study. J Am Coll Nutr. 2017;36(8):631-9.
97. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ. Maintaining alertness and performance during sleep deprivation: Modafinil versus caffeine. Psychopharmacology. 2002;159(3):238-47.
98. Kamimori GH, McLellan TM, Tate CM, Voss DM, Niro P, Lieberman HR. Caffeine improves reaction time, vigilance and logical reasoning during extended periods with restricted opportunities for sleep. Psychopharmacology. 2015;232(12):2031-42.
99. Tikuisis P, Keefe AA, McLellan TM, Kamimori G. Caffeine restores engagement speed but not shooting precision following 22 h of active wakefulness. Aviat Space Environ Med. 2004;75(9):771-6.
100. Walters ER, Lesk VE. Time of day and caffeine influence some neuropsychological tests in the elderly. Psychol Assessment. 2015;27(1):161-68.
101. Driscoll I, Shumaker SA, Snively BM, et al. Relationships between caffeine ıntake and risk for probable dementia or global cognitive impairment: The women's health initiative memory study. J Gerontol a-Biol 2016;71(12):1596-602.
102. Lorca C, Mulet M, Arevalo-Caro C, Sanchez MA, Perez A, Perrino M, et al. Plant-derived nootropics and human cognition: A systematic review. Crit Rev Food Sci Nutr. 2022:1-25.
103. Sprouse AA, van Breemen RB. Pharmacokinetic interactions between drugs and botanical dietary supplements. Drug Metab Dispos. 2015;44(2):162-71.